Hikma Pharmaceutical | HIK - المدينين التجاريين





المدينين التجاريين تغيير تاريخ
Almirall EUR 175.93M 17.87M 2025-12
argenx SE USD 1.66B 458.83M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Autolus Therapeutics Ltd USD 38.07M 37.71M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Fresenius EUR 3.78B 299M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.81B 373M 2026-03
Orion EUR 699.6M 270.4M 2026-03
Recordati EUR 764.73M 88.12M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12